Document is current
Any future updates will be listed below
-
Authors
Luke, Jason J.
Flaherty, Keith T.
Ribas, Antoni
Long, Georgina V.
- License Information
-
More Information
Article History
First Online: 4 April 2017
Competing interests
: J.J.L. has acted as a consultant for Amgen, Array, AstraZeneca, BeneVir, Bristol-Myers Squibb, CheckMate, EMD Serono, Gilead, Novartis, and Merck (non-paid). K.T.F. has been a consultant for Amgen, BMS, Merck, Novartis, and Roche. A.R. has acted as a consultant for Amgen, Array, BMS, Genentech-Roche, Merck MSD, and Novartis, and is a stock holder in Advaxis, Compugen, CytomX, Five Prime Therapeutics, and Kite Pharma. G.V.L. has been a consultant for Amgen, Array, BMS, Merck MSD, Novartis, Pierre-Fabre, and Roche.
Free to read: This content has been made available to all.
